Shares of Teleflex Inc. slipped 4.57% to $132.75 Friday, on what proved to be an all-around great trading session for the ...

Truist lowered the firm’s price target on Teleflex (TFX) to $149 from $200 and keeps a Hold rating on the shares. The firm says the company’s ...

Teleflex's business units, including urology and acute care will come under NewCo, with interventional and surgical under ...

Teleflex, whose shares sank nearly 20% Thursday, will acquire most of Biotronik’s vascular intervention assets. Teleflex also ...

Learn more about whether LeMaitre Vascular, Inc. or Teleflex Incorporated is a better investment based on AAII's A+ Investor ...

Teleflex to separate into two companies by mid-2026 and acquire Biotronik's Vascular Intervention unit for €760 million. CFO ...

Piper Sandler analyst Matt O’Brien downgraded Teleflex (TFX) to Neutral from Overweight with a price target of $140, down from $255. The ...

Teleflex has announced a plan to split its business into two separate independent companies—and it’s setting up one of its ...

Acquisition will further advance Teleflex’s Interventional portfolio with a differentiated global suite of coronary vascular ...

Teleflex Incorporated announced a plan to separate the company’s urology, acute care, and original equipment manufacture ...

Medical technology company Teleflex (NYSE:TFX) will be reporting earnings tomorrow before market open. Here’s what to look ...

Teleflex Inc. closed 44.33% below its 52-week high of $249.91, which the company reached on September 27th.